Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Autor:
Henning T. Mouridsen
Publikováno v:
Breast Cancer Research and Treatment
Tamoxifen has been a standard first-line endocrine therapy for post-menopausal women with hormone-responsive advanced breast cancer, but more than half of patients fail to respond and time to progression is less than 12 months in responders. The thir